Actavis, Inc. News Headlines

ACT 
$238.48
*  
2.80
1.16%
Get ACT Alerts
*Delayed - data as of Oct. 1, 2014  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Celgene Asserts More Revlimid Patents, Seeks New Ones To 2031
5/20/2014 6:07:00 PM - Seeking Alpha

Tracking Carl Icahn's Portfolio - Q1 2014 Update
5/20/2014 1:46:00 AM - Seeking Alpha

Legal Setback for Eli Lilly in the UK - Analyst Blog
5/16/2014 4:10:00 PM - Zacks.com

J.P.Morgan's Geoff Meacham Plucks Biotechs With Upside From A Down Market
5/16/2014 9:17:00 AM - Seeking Alpha

Thoughts On The Celgene Revlimid Markman Hearing
5/16/2014 9:15:00 AM - Seeking Alpha

SSO, ACE, ACT, ADBE: Large Outflows Detected at ETF
5/13/2014 11:00:07 AM - BNK Invest

Vivus Discloses Competitive Threat
5/10/2014 10:51:00 AM - Seeking Alpha

Acorda Misses on Earnings, Beats Revs - Analyst Blog
5/7/2014 1:43:01 PM - Zacks.com

Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog
5/2/2014 12:10:01 PM - Zacks.com

Avanir Wins Lawsuit, Shares Up - Analyst Blog
5/1/2014 4:39:01 PM - Zacks.com

Mylan Beats on Earnings, Misses on Sales - Analyst Blog
5/1/2014 1:17:01 PM - Zacks.com

Company News for May 01, 2014 - Corporate Summary
5/1/2014 10:06:01 AM - Zacks.com

Actavis Tops Q1 Earnings & Sales Estimates - Analyst Blog
4/30/2014 4:25:01 PM - Zacks.com

Zacks Rank #1 Additions for Wednesday - Tale of the Tape
4/30/2014 9:30:01 AM - Zacks.com

Why Earnings Season Could Be Great for Actavis (ACT) - Tale of the Tape
4/30/2014 8:30:01 AM - Zacks.com

Can Hospira (HSP) Keep the Earnings Streak Alive? - Analyst Blog
4/29/2014 5:10:01 PM - Zacks.com

Pre-Market Earnings Report for April 30, 2014 : TWX, PSX, NEE, D, SO, ADP, ACT, EXC, TRI, HES, WLP, CVE
4/29/2014 4:00:02 PM - NASDAQ.com News

Is Actavis (ACT) Poised to Beat Earnings Estimates? - Analyst Blog
4/29/2014 3:16:01 PM - Zacks.com

Forest Labs Beats Easily on 4Q Earnings - Analyst Blog
4/29/2014 12:10:01 PM - Zacks.com

Forest Labs to Buy Furiex for $1.1B - Analyst Blog
4/29/2014 9:00:01 AM - Zacks.com

Will Bristol-Myers (BMY) Beat Q1 Earnings? - Analyst Blog
4/28/2014 4:45:01 PM - Zacks.com

Will Forest Labs (FRX) Keep Its Earnings Streak Alive? - Analyst Blog
4/28/2014 4:40:01 PM - Zacks.com

Will Merck (MRK) Disappoint This Earnings Season? - Analyst Blog
4/28/2014 4:35:01 PM - Zacks.com

Cramer's Mad Money - 10 Things To Watch In The Week Ahead (4/25/14)
4/27/2014 6:29:00 AM - Seeking Alpha

Mallinckrodt (MNK) Jumps: Stock Rises 5.1% - Tale of the Tape
4/25/2014 8:57:01 AM - Zacks.com